These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 6235871
21. Immunological alterations in haemophiliacs treated with lyophilized Factor VIII cryoprecipitate from volunteer donors. Ceuppens JL, Vermylen J, Colaert J, Desmyter J, Gautama K, Stevens E, The AL, Vanham G, Vermylen C, Verstraete M. Thromb Haemost; 1984 Apr 30; 51(2):207-11. PubMed ID: 6429883 [Abstract] [Full Text] [Related]
23. HTLV III antibodies and immunological alterations in hemophilia patients. Seifried E, Pindur G, Stötter H, Porzsolt F, Rasche H, Erfle V, Hehlmann R, Heimpel H. Klin Wochenschr; 1986 Feb 03; 64(3):115-24. PubMed ID: 3005759 [Abstract] [Full Text] [Related]
24. Immunologic studies in asymptomatic hemophiliac patients. Frydecka I, Kowalewska B, Lesiecki A, Kuliczkowski K, Palakowska A, Polkowski A. Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Feb 03; 113(5):708-15. PubMed ID: 2435638 [Abstract] [Full Text] [Related]
25. Use of heat-treated clotting-factor concentrates in patients with haemophilia and a high exposure to HTLV-III. McGrath KM, Thomas KB, Herrington RW, Turner PJ, Taylor L, Ekert H, Schiff P, Gust ID. Med J Aust; 1985 Jul 08; 143(1):11-3. PubMed ID: 2989666 [Abstract] [Full Text] [Related]
27. Decreased helper/suppressor cell ratios after treatment with factor VIII and IX concentrates and fresh frozen plasma. Ragni MV, Lewis JH, Spero JA, Bontempo FA, Rabin BS. Am J Med; 1984 Feb 08; 76(2):206-10. PubMed ID: 6230009 [Abstract] [Full Text] [Related]
31. Transfusion support for haemophiliacs. Allain JP. Clin Haematol; 1984 Feb 08; 13(1):99-117. PubMed ID: 6426835 [No Abstract] [Full Text] [Related]
32. A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses. Stein SF, Evatt BL, McDougal JS, Lawrence DN, Holman RC, Ramsey RB, Spira TJ. Blood; 1985 Oct 08; 66(4):973-9. PubMed ID: 2994784 [Abstract] [Full Text] [Related]
33. AIDS and preventive treatment in hemophilia. Desforges JF. N Engl J Med; 1983 Jan 13; 308(2):94-5. PubMed ID: 6216409 [No Abstract] [Full Text] [Related]
35. Abnormal T-cell subpopulations in hemophilic patients receiving factor VIII concentrates from voluntary donors. Wearne A, Joshua DE, Rickard KA, Kronenberg H. Aust N Z J Med; 1984 Apr 13; 14(2):149-53. PubMed ID: 6236788 [Abstract] [Full Text] [Related]
36. Alterations in T-lymphocyte subsets among Danish haemophiliacs: relation to source of factor VIII preparations and high dose factor VIII treatment. Gerstoft J, Bentsen K, Scheibel E, Dalsgård-Nielsen J, Gormsen J, Dickmeiss E. Scand J Haematol; 1984 May 13; 32(5):544-51. PubMed ID: 6328639 [Abstract] [Full Text] [Related]
38. Some evidence for the in vivo functional activation of suppressor T cells in asymptomatic patients with hemophilia A receiving Factor VIII concentrates. Seki H, Taga K, Nagaoki T, Barot-Ciorbaru R, Miyawaki T, Taniguchi N. Clin Immunol Immunopathol; 1985 Jan 13; 34(1):27-38. PubMed ID: 3155504 [Abstract] [Full Text] [Related]
39. Abnormal T-cell subsets and mitogen responses in hemophiliacs exposed to factor concentrate. Unzeitig JC, Church JA, Gomperts ED, Nye CA, Pasquale S, Richards W. Am J Dis Child; 1984 Jul 13; 138(7):645-8. PubMed ID: 6233901 [Abstract] [Full Text] [Related]
40. The efficacy and safety of lyophilized cryoprecipitate in hemophilia A. Chuansumrit A, Isarangkura P, Chantanakajornfung A, Kuhathong K, Pintadit P, Jitpraphai C, Hathirat P, Nuchprayoon C. J Med Assoc Thai; 1999 Nov 13; 82 Suppl 1():S69-73. PubMed ID: 10730521 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]